Display options
Cite
Carnes N, Zhang J, Gelaude D, et al. Restricting Access: A Secondary Analysis of Scope of Practice Laws and Pre-exposure Prophylaxis Prescribing in the United States, 2017. J Assoc Nurses AIDS Care. 2022;33(1):89-97doi: 10.1097/JNC.0000000000000275.
Carnes, N., Zhang, J., Gelaude, D., Huang, Y. A., Mizuno, Y., & Hoover, K. W. (2022). Restricting Access: A Secondary Analysis of Scope of Practice Laws and Pre-exposure Prophylaxis Prescribing in the United States, 2017. The Journal of the Association of Nurses in AIDS Care : JANAC, 33(1), 89-97. https://doi.org/10.1097/JNC.0000000000000275
Carnes, Neal, et al. "Restricting Access: A Secondary Analysis of Scope of Practice Laws and Pre-exposure Prophylaxis Prescribing in the United States, 2017." The Journal of the Association of Nurses in AIDS Care : JANAC vol. 33,1 (2022): 89-97. doi: https://doi.org/10.1097/JNC.0000000000000275
Carnes N, Zhang J, Gelaude D, Huang YA, Mizuno Y, Hoover KW. Restricting Access: A Secondary Analysis of Scope of Practice Laws and Pre-exposure Prophylaxis Prescribing in the United States, 2017. J Assoc Nurses AIDS Care. 2022 Jan-Feb 01;33(1):89-97. doi: 10.1097/JNC.0000000000000275. PMID: 34086636.
Copy Download .nbib Format: NLM
Share it on

J Assoc Nurses AIDS Care. 2022 Jan-Feb 01;33(1):89-97. doi: 10.1097/JNC.0000000000000275.

Restricting Access: A Secondary Analysis of Scope of Practice Laws and Pre-exposure Prophylaxis Prescribing in the United States, 2017.

The Journal of the Association of Nurses in AIDS Care : JANAC

Neal Carnes, Jun Zhang, Deborah Gelaude, Ya-Lin A Huang, Yuko Mizuno, Karen W Hoover

Affiliations

  1. Neal Carnes, PhD, is a Health Scientist, Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. Jun Zhang, MD, MSPH, is the Associate Director in CORE at Merck & Co, Kenilworth, New Jersey, and was an Epidemiologist, Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA, at the time this analysis was conducted. Deborah Gelaude, MA, is a Behavioral Scientist, Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. Ya-lin A. Huang, PhD, is a Senior Service Fellow, Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. Yuko Mizuno, PhD, is a Behavioral Scientist and Associate Chief of Science, Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. Karen W. Hoover, MD, MPH, is a Medical Epidemiologist and Team Lead, Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

PMID: 34086636 DOI: 10.1097/JNC.0000000000000275

Abstract

ABSTRACT: To assess advanced practitioners' scope of practice laws (i.e., legal authority providers can prescribe regulated medications) as potential barriers to HIV pre-exposure prophylaxis (PrEP), we conducted an analysis using IQVIA Real World Data in association with scope of practice law classifications supplied by the American Association of Nurse Practitioners and scopeofpracticepolicy.org. Nurse practitioners in states that allowed independent scope of practice were 1.4 times more likely to have prescribed PrEP compared with nurse practitioners in states where their prescribing authority is determined by a supervising medical doctor (MD). Physician assistants in states where the law or a state board defined their prescribing authority were more than twice as likely to prescribe PrEP compared with those in states where a supervising MD oversaw prescribing rights. Our findings suggest that restricting scope of prescribing practice by requiring MD oversight limits PrEP access and poses a barrier to scaling up PrEP.

Copyright © 2021 Association of Nurses in AIDS Care.

References

  1. American Association of Nurse Practitioners. (2017). State practice environment. Retrieved December 7, 2017 from https://www.aanp.org/advocacy/state/state-practice-environment - PubMed
  2. American Nurses Association. (n.d.). Scope of practice. Retrieved May 21, 2021, from https://www.nursingworld.org/practice-policy/scope-of-practice/ - PubMed
  3. Barnes H., Richards M. R., McHugh M. D., Martsolf G. (2018). Rural and nonrural primary care physician practices increasingly rely on nurse practitioners. Health Affairs, 37(6), 908-914. https://doi.org/https://doi.org/10.1377/hlthaff.2017.1158 - PubMed
  4. Calabrese S. K., Earnshaw V. A., Underhill K., Hansen N. B., Dovidio J. F. (2014). The impact of patient race on clinical decisions related to prescribing HIV pre-exposure prophylaxis (PrEP): Assumptions about sexual risk compensation and implications for access. AIDS and Behavior, 18(2), 226-240. https://doi.org/https://doi.org/10.1007/s10461-013-0675-x - PubMed
  5. Cawley J. F. (2012). Physician assistants and their role in primary care. American Medical Association's Journal of Ethics, 14(5), 411-414. https://doi.org/10.1001/virtualmentor.2012.14.5.pfor2-1205 - PubMed
  6. Centers for Disease Control and Prevention. (2018a). Diagnoses for HIV infection among adolescents and young adults in the United States and 6 dependent areas, 2011-2016. https://www.cdc.gov/hiv/pdf/library/reports/surveillance/cdc-hiv-surveillance-supplemental-report-vol-23-3.pdf - PubMed
  7. Centers for Disease Control and Prevention. (2018b). HIV surveillance report, 2017. https://www.cdc.gov/hiv/pdf/library/reports/surveillance/cdc-hiv-surveillance-report-2017-vol-29.pdf - PubMed
  8. Dominguez K. L., Smith D. K., Thomas V., Crepaz N., Lang K., Heneine W., McNicholl J. M., Reid L., Freelon B., Nesheim S. R. (2016). Updated guidelines for antiretroviral postexposure prophylaxis after sexual, injection drug use, or other nonoccupational exposure to HIV—United States, 2016. https://stacks.cdc.gov/view/cdc/38856 - PubMed
  9. Elion R., Coleman M. (2016). The preexposure prophylaxis revolution: from clinical trials to routine practice: implementation view from the USA. Current Opinion in HIV and AIDS, 11(1), 67-73. https://doi.org/10.1097/COH.0000000000000222 - PubMed
  10. Elopre L., Kudroff K., Westfall A. O., Overton E. T., Mugavero M. J. (2017). The right people, right places, and right practices: disparities in PrEP access among African American men, women and MSM in the Deep South. Journal of Acquired Immune Deficiency Syndromes, 74(1), 56. https://doi.org/10.1097/QAI.0000000000001165 - PubMed
  11. Fauci A. S., Redfield R. R., Sigounas G., Weahkee M. D., Giroir B. P. (2019). Ending the HIV epidemic: A plan for the United States ending the HIV epidemic editorial. JAMA, 321(9), 844-845. https://doi.org/10.1001/jama.2019.1343 %J JAMA - PubMed
  12. Goparaju L., Praschan N. C., Warren-Jeanpiere L., Experton L. S., Young M. A., Kassaye S. (2017). Stigma, partners, providers and costs: Potential barriers to PrEP uptake among US women. Journal of AIDS & Clinical Research, 8(9), 730. https://doi.org/10.4172/2155-6113.1000730 - PubMed
  13. Health Resources and Services Administration. (2018a). Table 3B: Demographic characteristics. Retrieved May 21, 2021, from https://data.hrsa.gov/tools/data-reporting/program-data/national/table?tableName=3B&year=2018 - PubMed
  14. Health Resources and Services Administration. (2018b). Table 5: Staffing and utilization. Retrieved May 21, 2021, from https://data.hrsa.gov/tools/data-reporting/program-data/national/table?tableName=5&year=2018 - PubMed
  15. Health Resources and Services Administration. (July 2019). Ending the HIV epidemic: A plan for America. Retrieved May 21, 2021, from https://www.hrsa.gov/ending-hiv-epidemic - PubMed
  16. Hershow R. B., Gonzalez M., Costenbader E., Zule W., Golin C., Brinkley-Rubinstein L. (2019). Medical providers and harm reduction views on pre-exposure prophylaxis for HIV prevention among people who inject drugs. Journal of AIDS Education and Prevention, 31(4), 363-379. - PubMed
  17. Jones J., Sullivan P. S., Curran J. W. (2019). Progress in the HIV epidemic: Identifying goals and measuring success. PLoS Medicine, 16(1), e1002729. https://doi.org/10.1371/journal.pmed.1002729 - PubMed
  18. Kurtzman E. T., Barnow B. S. (2017). A comparison of nurse practitioners, physician assistants, and primary care physicians' patterns of practice and quality of care in health centers. Medical Care, 55(6), 615-622. https://doi.org/10.1097/MLR.0000000000000689 - PubMed
  19. Lelutiu-Weinberger C., Golub S. A. (2016). Enhancing PrEP access for Black and Latino men who have sex with men. Journal of Acquired Immune Deficiency Syndromes, 73(5), 547. https://doi.org/10.1097/QAI.0000000000001140 - PubMed
  20. Mayer K. H., Chan P. A., Patel R., Flash C. A., Krakower D. S. (2018). Evolving models and ongoing challenges for HIV pre-exposure prophylaxis implementation in the United States. Journal of Acquired Immune Deficiency Syndromes, 77(2), 119. https://doi.org/10.1097/QAI.0000000000001579 - PubMed
  21. Morgan P., Everett C., Hing E. (2015). Nurse practitioners, physician assistants, and physicians in community health centers, 2006-2010. Healthcare (Amsterdam, Netherlands), 3(2), 102-107. https://doi.org/10.1016/j.hjdsi.2014.06.002 - PubMed
  22. National Council of State Legislators, & Association of State and Territorial Health Officials. (2018). Scope of practice policy. Retrieved February 16, 2018, from http://scopeofpracticepolicy.org/ - PubMed
  23. Pérez-Figueroa R. E., Kapadia F., Barton S. C., Eddy J. A., Halkitis P. N. (2015). Acceptability of PrEP uptake among racially/ethnically diverse young men who have sex with men: The P18 study. AIDS Education and Prevention, 27(2), 112-125. https://doi.org/https://doi.org/10.1521/aeap.2015.27.2.112 - PubMed
  24. Petroll A. E., Walsh J. L., Owczarzak J. L., McAuliffe T. L., Bogart L. M., Kelly J. A. (2017). PrEP awareness, familiarity, comfort, and prescribing experience among US primary care providers and HIV specialists. AIDS and Behavior, 21(5), 1256-1267. https://doi.org/10.1007/s10461-016-1625-1 - PubMed
  25. Smith D. K., Mendoza M. C., Stryker J. E., Rose C. E. (2016). PrEP awareness and attitudes in a national survey of primary care clinicians in the United States, 2009-2015. PloS One, 11(6), e0156592. https://doi.org/https://doi.org/10.1371/journal.pone.0156592 - PubMed
  26. Smith D. K., Van Handel M., Grey J. (2018). Estimates of adults with indications for HIV pre-exposure prophylaxis by jurisdiction, transmission risk group, and race/ethnicity, United States, 2015. Annals of Epidemiology, 28(12), 850-857.e9. https://doi.org/10.1016/j.annepidem.2018.05.003 - PubMed
  27. United States Census Bureau. (2019). 2017 ACS 1-year estimates. https://www.census.gov/programs-surveys/acs/technical-documentation/table-and-geography-changes/2017/1-year.html - PubMed
  28. Weiss K., Bratcher A., Sullivan P., Siegler A. (2018). Geographic access to prep clinics among us MSM: Documenting PrEP deserts [Poster presentation]. Conference on Retroviruses and Opportunistic Infections, Boston, Massachusetts. https://www.natap.org/2018/CROI/1430_Weiss_1006eecopy.pdf - PubMed
  29. Wu H., Mendoza M. C., Huang Y.-l. A., Hayes T., Smith D. K., Hoover K. W. (2016). Uptake of HIV preexposure prophylaxis among commercially insured persons—United States, 2010-2014. Clinical Infectious Diseases, 64(2), 144-149. https://doi.org/https://doi.org/10.1093/cid/ciw701 - PubMed
  30. Ya-lin A. H., Zhu W., Smith D. K., Harris N., Hoover K. W. (2018). HIV preexposure prophylaxis, by race and ethnicity—United States, 2014-2016. MMWR Morbidity and Mortality Weekly Report, 67(41), 1147. https://doi.org/10.15585/mmwr.mm6741a3 - PubMed

Publication Types